Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
It is intended for contrast enhancement in MRI scans
Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody, targeting a known biological driver of Parkinson’s disease progression
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
Subscribe To Our Newsletter & Stay Updated